🚺 Breakthroughs in Women’s Health: Sexual Wellness, HIV, Menopause, and More
This week’s Women’s Health Update delivers the latest on innovative treatments, global health initiatives, and major policy developments impacting women worldwide.
🔬 Key highlights:
💄 Daré Bioscience & Rosy Wellness launch the first prescription topical sildenafil cream for female arousal, alongside educational campaigns to combat misinformation.
⚖️ RFK Jr. proposes a full overhaul of the U.S. Preventive Services Task Force, raising concerns over HIV PrEP access, including new twice-yearly prevention drugs.
🌡️ Bayer’s Elinzanetant faces an FDA review extension, but remains on track as the first dual NK1/NK3 antagonist for hormone-free menopause symptom relief.
đź’‰ EMA recommends Yeytuo, a twice-yearly HIV prevention injection that achieved near-zero infection rates in pivotal trials.
🦠NHS rolls out the world’s first gonorrhoea vaccine programme, aiming to prevent 100,000 cases and curb antibiotic-resistant strains.
⚖️ Meta found liable for misusing reproductive health data, with potential damages reaching 190 billion dollars.
đź’Š Noom introduces a low-dose, affordable semaglutide alternative to Wegovy for obesity treatment.
🧬 Celcuity’s Gedatolisib achieves historic Phase 3 results in advanced breast cancer, with up to 76 percent risk reduction in disease progression.
💰 Gates Foundation pledges 2.5 billion dollars to women’s health research, targeting over 40 innovations in reproductive and maternal care.
📢 Stay Ahead in Women’s Health Research!
✅ Like, share, and subscribe for weekly updates on women’s health, reproductive medicine, neurology, and global public health
#WomensHealth #ReproductiveHealth #HIVPrevention #Menopause #GonorrhoeaVaccine #HealthPolicy #BreastCancer #ObesityTreatment #Pharmaceuticals #LucidQuest #MedicalNews #HealthcareInnovation #ClinicalTrials